NextCure to merge with Avere Therapeutics.
NextCure, Inc. entered into a definitive merger and reorganization agreement with Avere Therapeutics and its subsidiaries on July 14, 2026. This strategic corporate transaction aims to combine their biopharmaceutical pipelines and enhance combined market capabilities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day